Raimond et al. [59] reported heterogeneity in KRAS gene mutations between CRC tissues and CTCs, with a higher frequency of KRAS gene mutations in CTCs than in CRC tissues, and a lack of heterogeneity in KRAS gene mutation expression among paired samples. Here, KRAS is linked to colorectal carcinoma.